ISRCTN14463242进行中（未招募）未知
Patient and family involvement in serious incident investigations: Developing and testing national and local guiding processes
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 61
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Patient and family
- •1. Experienced a ‘serious’ incident as defined by the Trust
- •2. The serious incident is new (occurring in the last few days)
- •3. There is no police involvement
- •4. They are >16 years of age
- •5. They have capacity to consent to the interview
- •Investigators
- •1. Experience of conducting serious incident investigations
- •1. Directly involved in the serious incident
排除标准
- •Does not meet inclusion criteria
研究者
相似试验
招募中
不适用
The effect of education on Cardiac Surgery patients and their familyIRCT20161124031068N3Tehran University of Medical Sciences90
招募中
不适用
Experience of Transfers to Rehabilitation ServicesPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationStroke - HaemorrhagicStroke - IschaemicstrokeACTRN12620000062921Auckland DHB400
招募中
不适用
Coronary Artery calcium score: Use to Guide management of Hereditary Coronary Artery DiseaseCoronary artery diseaseCardiovascular - Coronary heart diseaseACTRN12614001294640Baker-IDI Heart and Diabetes Institute734
招募中
不适用
Experiences of the use of the English version of an iPad application Aid for decision-making in occupation choice ,(ADOC-E), for shared decision making around goal setting in rehabilitation: a qualitative descriptive studyPhysical rehabilitationPhysical Medicine / Rehabilitation - Occupational therapyPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationPhysical Medicine / Rehabilitation - PhysiotherapyPhysical Medicine / Rehabilitation - Speech therapyInjuries and Accidents - Other injuries and accidentsACTRN12620001328965niversity of Otago18
尚未招募
不适用
How useful is spirometry during and following exacerbations of chronic obstructive pulmonary disease?COPD exacerbationsRespiratory - Chronic obstructive pulmonary diseaseACTRN12610000745044GlaxoSmithKline (GSK)48